跳至主要内容
临床试验/NCT01170728
NCT01170728终止不适用

Virtue® Male Sling Fixation Study

Coloplast A/S10 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Coloplast A/S
入组人数
44
试验地点
10
主要终点
Improvement of incontinence

研究概览

简要总结

This study is a multi-center study that will assess the efficacy and safety of suture fixation of the Virtue® Male Sling.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male subject at least 18 years of age with an estimated life expectancy of of more than 5 years
  • The subject has confirmed stress urinary incontinence (SUI) through medical history , urodynamics, and/or physical exam for at least 6 months
  • The subject has completed post-void residual per protocol within 6 weeks prior to implant
  • The subject has completed cystoscopy as per protocol within 12 months prior to implant
  • The subject has intrinsic sphincter deficiency due to one of the following: post-transurethral resection of the prostate (TURP), simple open prostatectomy, or radical prostatectomy completed at least 6 months prior to implantation date
  • The subject has failed at least two non-invasive therapies, eg. pelvic/Kegel exercises, behavioral modification or biofeedback for at least 6 months
  • The subject is willing to have the Virtue® Male Sling implanted
  • The subject is able and willing to complete all follow-up visits and procedures indicated in the protocol
  • The subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the local ethics committee of the respective site

排除标准

  • The subject is unable or unwilling to sign the informed consent form (ICF)and/or comply with all follow-up requirements according to the study protocol
  • The subject has an active urinary tract infection or active skin infection in region of surgery
  • The subject has serious bleeding disorders
  • The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, cerebrovascular accident (CVA), detrusor-external sphincter dyssynergia, Parkinson's disease, or similar condition
  • The subject had a previous implant to treat stress urinary incontinence
  • The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months
  • The subject is likely to undergo radiation therapy within the next 6 months
  • The subject has active urethral or bladder neck stricture disease requiring continued treatment
  • The subject has urge predominant incontinence
  • The subject has an atonic bladder or a postvoid residual (PVR) greater than or equal to 150 milliliters (mL)
  • The subject has a condition or disorder likely to require future transurethral procedure
  • The subject is enrolled in a concurrent clinical study of any treatment (drug or device) that could affect continence function without sponsor's approval
  • The subject is deemed unfit for male sling implantation or participation in a research protocol as determined by attending physician

结局指标

主要结局

Improvement of incontinence

时间窗: 3 months post implant

Safety of the device characterized by reported adverse events

时间窗: 3 months

次要结局

  • To characterize incontinence severity at various time points(24 months)
  • To evaluate patient quality of life at specified time points(24 months)

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验